Curis | CRIS - Equity Capital And Reserves


Curis reported $5.46M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 1.29M 865K Mar/2026
Amgen USD 9.19B 532M Mar/2026
AstraZeneca USD 47.33B 1.33B Mar/2026
Bayer EUR 28.85B 2.9B Mar/2026
Bristol-Myers Squibb USD 20.07B 1.6B Mar/2026
CSL USD 18.66B 2.75B Dec/2025
Curis USD 5.46M 19.45M Dec/2025
Eli Lilly USD 31.2B 4.66B Mar/2026
Exelixis USD 1.94B 225.57M Mar/2026
Gilead Sciences USD 23.52B 897M Mar/2026
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
Incyte USD 5.62B 455.37M Mar/2026
Merck USD 45.88B 6.73B Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Pfizer USD 90.1B 3.63B Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 72.81B 1.1B Mar/2026
Takeda JPY 7.77T 129.5B Mar/2026
TG Therapeutics USD 583.13M 64.89M Mar/2026
Verastem USD 57.2M 72.72M Dec/2025
Xoma USD 87.94M 15.5M Sep/2025